Ribas A - Search Results

1

CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans.

Huang RR, Jalil J, Economou JS, Chmielowski B, Koya RC, Mok S, Sazegar H, Seja E, Villanueva A, Gomez-Navarro J, Glaspy JA, Cochran AJ, Ribas A. Huang RR, et al. Among authors: ribas a. Clin Cancer Res. 2011 Jun 15;17(12):4101-9. doi: 10.1158/1078-0432.CCR-11-0407. Epub 2011 May 10. Clin Cancer Res. 2011. PMID: 21558401 Free PMC article. Clinical Trial.

2

Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells.

Ribas A, Butterfield LH, McBride WH, Jilani SM, Bui LA, Vollmer CM, Lau R, Dissette VB, Hu B, Chen AY, Glaspy JA, Economou JS. Ribas A, et al. Cancer Res. 1997 Jul 15;57(14):2865-9. Cancer Res. 1997. PMID: 9230191

3

In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2.

Bui LA, Butterfield LH, Kim JY, Ribas A, Seu P, Lau R, Glaspy JA, McBride WH, Economou JS. Bui LA, et al. Among authors: ribas a. Hum Gene Ther. 1997 Dec 10;8(18):2173-82. doi: 10.1089/hum.1997.8.18-2173. Hum Gene Ther. 1997. PMID: 9449371

4

Endothelium-specific expression of an E-selectin promoter recombinant adenoviral vector.

Walton T, Wang JL, Ribas A, Barsky SH, Economou J, Nguyen M. Walton T, et al. Among authors: ribas a. Anticancer Res. 1998 May-Jun;18(3A):1357-60. Anticancer Res. 1998. PMID: 9673340

5

Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus.

Butterfield LH, Jilani SM, Chakraborty NG, Bui LA, Ribas A, Dissette VB, Lau R, Gamradt SC, Glaspy JA, McBride WH, Mukherji B, Economou JS. Butterfield LH, et al. Among authors: ribas a. J Immunol. 1998 Nov 15;161(10):5607-13. J Immunol. 1998. PMID: 9820539

6

Antitumor protection using murine dendritic cells pulsed with acid-eluted peptides from in vivo grown tumors of different immunogenicities.

Ribas A, Bui LA, Butterfield LH, Vollmer CM, Jilani SM, Dissette VB, Glaspy JA, McBride WH, Economou JS. Ribas A, et al. Anticancer Res. 1999 Mar-Apr;19(2A):1165-70. Anticancer Res. 1999. PMID: 10368670

7

Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma.

Vollmer CM Jr, Eilber FC, Butterfield LH, Ribas A, Dissette VB, Koh A, Montejo LD, Lee MC, Andrews KJ, McBride WH, Glaspy JA, Economou JS. Vollmer CM Jr, et al. Among authors: ribas a. Cancer Res. 1999 Jul 1;59(13):3064-7. Cancer Res. 1999. PMID: 10397245

8

Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein.

Butterfield LH, Koh A, Meng W, Vollmer CM, Ribas A, Dissette V, Lee E, Glaspy JA, McBride WH, Economou JS. Butterfield LH, et al. Among authors: ribas a. Cancer Res. 1999 Jul 1;59(13):3134-42. Cancer Res. 1999. PMID: 10397256

9

p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma.

Vollmer CM, Ribas A, Butterfield LH, Dissette VB, Andrews KJ, Eilber FC, Montejo LD, Chen AY, Hu B, Glaspy JA, McBride WH, Economou JS. Vollmer CM, et al. Among authors: ribas a. Cancer Res. 1999 Sep 1;59(17):4369-74. Cancer Res. 1999. PMID: 10485485

10

Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cells.

Ribas A, Butterfield LH, McBride WH, Dissette VB, Koh A, Vollmer CM, Hu B, Chen AY, Glaspy JA, Economou JS. Ribas A, et al. Cancer Gene Ther. 1999 Nov-Dec;6(6):523-36. doi: 10.1038/sj.cgt.7700076. Cancer Gene Ther. 1999. PMID: 10608349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

731 results

Search Page

Filters